Research provides patients with the best, most up-to-date treatments for their illnesses while evaluating new treatments to help future children. At Phoenix Children's Hospital, this translates into cutting edge care and access to the most promising new options.
Phoenix Children's also collaborates with a number of local, national and international partners, sharing data with institutions worldwide in the search of the best treatments and cures. These include major national and international universities and research institutes along with the National Institutes of Health, the National Cancer Institute and major Foundations such as Saint Baldricks, Alex Lemonade Stand, CureSearch and Hyundai. There are also collaborations with a wide range of pharmaceutical and bioinformatic companies.
The Ronald A. Matricaria Institute of Molecular Medicine - established in December 2012 - works to unlock genetic codes and develop drug therapies to improve the outcome for thousands of young patients.
Key local institutions we collaborate with include:
- The University of Arizona College of Medicine – Phoenix brings academic and research programs, as well as academic credentials necessary to recruit and develop a research program.
- The Translational Genomics Research Institute (TGen) contributes deep expertise in genomics and bioinformatics and sophisticated laboratory space.
- Arizona State University provides collaborative projects in biomedical engineering, proteomics and nanotechnologies.
- Arizona Bio-Specimen Alliance (ABA)
- Mayo Clinic Arizona
Additional research partners and affiliations include:
- Children's Oncology Group (COG)
- Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC)
- Sarcoma Alliance through Research Collaboration (SARC)
- Translational Genomics Institute (TGen)
- Pediatric Bone Marrow Transplant Consortium (PBMTC)
- North American Pediatric Aplastic Anemia Consortium (NAPAAC)
- Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC)